Under Trump, Antitrust Regulators May Be More Divestiture Friendly

 
• By Tim Casey
  
The FTC could continue targeting so-called "roll-up" strategies, which are used to creating negotiating leverage with payers. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Litigation

More from United States